Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

GENSIA SUBSIDIARY GETS NDA APPROVAL

Feb. 7, 1992

REGENERON ACQUIRES LICENSES FOR GMF

Feb. 6, 1992

APPLIED MICRO EXTENDS WARRANTS DEADLINE

Feb. 6, 1992

CLASS-ACTION SUIT AGAINST XYTRONYX

Feb. 6, 1992

GENETIC REGIONS THAT CAUSE MD

Feb. 6, 1992

IMMUNOMEDICS GETS SBIR

Feb. 6, 1992

VCS OPTIMISTIC ABOUT 1992

Feb. 6, 1992

METRA RAISES $6 MILLION IN FINANCING

Feb. 6, 1992

ECOSCIENCE RAISES $28.6 MILLION IN IPO

Feb. 6, 1992

VESTAR OFFERING RAISES $50 MILLION

Feb. 6, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.